Eric Van Den Neste, Marc André, Thomas Gastinne, Aspasia Stamatoullas, Corinne Haioun, Amine Belhabri, Oumedaly Reman, Olivier Casasnovas, Hervé Ghesquieres, Gregor Verhoef, Marie-José Claessen, Hélène A. Poirel, Marie-Christine Copin, Romain Dubois, Peter Vandenberghe, Ioanna-Andrea Stoian, Anne S. Cottereau, Sarah Bailly, Laurent Knoops, and Franck Morschhauser. 2018. “A Phase II Study of the Oral JAK1/JAK2 Inhibitor Ruxolitinib in Advanced relapsed/Refractory Hodgkin Lymphoma”. Haematologica 103 (5). Pavia, Italy, 840-48. https://doi.org/10.3324/haematol.2017.180554.